anti-CD19-CAR vector-transduced T cells

BIOLOGICAL2 trials

Conditions

Adult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic LeukemiaHematopoietic/Lymphoid CancerMantle Cell LymphomaNon-hodgkin Lymphoma,B CellProlymphocytic LeukemiaRecurrent Adult Diffuse Large Cell Lymphoma

Phase 1

CART-19 Immunotherapy in Mantle Cell Lymphoma

NCT02081937

Chinese PLA General HospitalHematopoietic/Lymphoid Cancer, Mantle Cell Lymphoma, Non-hodgkin Lymphoma,B Cell

Start: 2014-03-31End: 2019-12-31Target: 2Updated: 2014-03-11

Unknown Phase

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19

NCT01864889

Chinese PLA General HospitalAdult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia +20

Start: 2013-04-30End: 2017-04-30Target: 12Updated: 2016-01-28

2018-03-296 citations

Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia

OncoImmunology2015-05-26164 citations

anti-CD19-CAR vector-transduced T cells

Sponsors

Conditions

Phase 1

Unknown Phase

Related Papers